Chest radiograph or CT abnormality | Acute or subacute onset | Chronic onset |
Focal consolidation | Any organism, but especially pyogenic bacteria Legionellosis | Mycobacteriosis Nocardiosis Fungi (aspergillosis, endemic fungal infections, cryptococcosis) |
Diffuse interstitial infiltrate | Pneumocystis jirovecii Bacteria, especially Haemophilus influenzae (influenza, CMV) | Mycobacteriosis Fungal pneumonia, especially cryptococcal Toxoplasmosis CMV |
Nodules | Tuberculosis Fungi (cryptococosis, aspergillosis) Bacteria | Nocardiosis Fungi |
Adenopathy | Tuberculosis | Mycobacteriosis Endemic fungal infections |
Cavitary infiltrate | Tuberculosis Staphylococcus aureus (IDU) Fungi Anaerobes Pseudomonas aeruginosa Legionellosis | Mycobacteriosis Nocardiosis Fungi Rhodococcus equi |
Pleural effusion | Pyogenic bacteria Fungi Tuberculosis | Fungi Nocardiosis |
Pneumothorax | Pneumocystis jirovecii |
CT: computed tomography; CMV: cytomegalovirus; IDU: intravenous drug users. Patients with acute, subacute or chronic onset have <1 week, 1–4 weeks or >4 weeks of symptoms, respectively.